Glucocorticoid induced bone disorders in children: Research progress in treatment mechanisms

Junying Hua1, Jianping Huang2, Gang Li3,4

  • 1Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Zhanjiang, China.

Insights

Glucocorticoids (GCs) impair bone growth in children, causing growth retardation. Traditional Chinese Medicine offers a promising alternative to mitigate these severe side effects and protect skeletal development.

Area of Science:

  • Pediatric endocrinology
  • Bone biology
  • Pharmacology

Background:

  • Supra-physiological glucocorticoid (GC) use causes significant skeletal side effects, particularly in children.
  • GCs impede endochondral ossification in growth plates, leading to growth retardation and osteoporosis.
  • Current osteoporosis treatments are ineffective against GC-induced longitudinal bone growth disorders.

Purpose of the Study:

  • To review research on GC-induced growth and development disorders.
  • To explore novel therapeutic strategies for mitigating GC side effects.
  • To provide insights for developing drugs to prevent GC-related skeletal complications.

Main Methods:

  • Comprehensive literature review of GC effects on skeletal development.
  • Analysis of current therapeutic limitations for GC-induced bone disorders.
  • Exploration of Traditional Chinese Medicine as a potential treatment avenue.

Main Results:

  • GCs severely impact pediatric bone growth via growth plate dysfunction.
  • No specific drugs currently exist to counteract GC-induced longitudinal bone growth impairment.
  • Traditional Chinese Medicine presents a potential alternative for managing GC side effects.

Conclusions:

  • GCs pose a significant risk to pediatric skeletal development.
  • There is an unmet need for targeted therapies against GC-induced bone growth disorders.
  • Further research into Traditional Chinese Medicine may yield novel treatments for steroid-related side effects.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
164
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
210
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K